Lenfadenopatiler Sistemik Lupus Eritematozuslu Hastalarda Hastalık Alevlenmesinin Habercisi Olabilir

p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 8.0px Times; color: #6b6a6a} p.p2 {margin: 0.0px 0.0px 0.0px 0.0px; font: 8.0px Helvetica; color: #6b6a6a} span.s1 {font: 8.0px Helvetica} Lenfadenopati, sistemik lupus eritamatozus (SLE) seyrinde sık görülen bir bulgudur. Öte yandan enfeksiyonlar, malign hastalıklar ve diğer immünolojik hastalıklar da SLE seyrinde ortaya çıkıp lenfadenopatiye neden olabilirler. Bu yüzden ayırıcı tanı büyük önem taşır. Lenfadenopati saptanan SLE’li hastalarda hastalık aktivitesinin daha yüksek olduğu belirtilmektedir. Ancak aktivasyonun ilk bulgusu olması nadirdir. Bu makalede hastalık aktivasyonunun başlangıç bulgusu lenfadenopati olan bir SLE olgusu sunulmuştur.

Anahtar Kelimeler:

Lenfadenopati, nüks, sistemik lupus eritematozu

Lymphadenopathies May Be Presenting Sign Of Disease Exacerbation In Patients With Systemic Lupus Erythematosus

Lymphadenopathy is frequently seen in the course of systemic lupus erythematosus (SLE). On the other hand,infections, malignant and other immunological disorders are the reasons of lymphadenopathies. Therefore, differential diagnosis is very important. It is mentioned that SLE patients with lymphadenopathy has been found to have higher disease activity. But, lymphadenopathy as the first clinical manifestation of the disease activation is very rare. Herein, a SLE case that has lymphadenopathy as a presentation sign of active disease was reported. p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 8.0px Helvetica; color: #6b6a6a}

Keywords:

Lymphadenopathy, recurrence, systemic lupus erythematosus,

PDF

___

1. Calgüneri M, Oztürk MA, Ozbalkan Z, et al. Frequency of lymphadenopathy in rheumatoid arthritis and systemic lupus erythematosus. J Int Med Res 2003; 31: 345-9.
2. Shapira Y, Weinberger A, Wysenbeek AJ. Lymphadenopathy in systemic lupus erythematosus. Prevalence and relation to disease manifestations. Clin Rheumatol 1996; 15: 335-8.
3. Melikoglu MA, Melikoglu M. The clinical importance of lymphadenopathy in systemic lupus erythematosus. Acta Reumatol Port 2008; 33: 402-6.
4. Bukiej A, Undas A, Pituch-Noworolska A, Chmielewska A, Dyczek A, Musiał J. Association of peripheral lymphadenopathy with anti-Ro and anti-La antibodies in a family with systemic lupus erythematosus. Scand J Rheumatol 2003; 32: 52-4.
5. Kitsanou M, Andreopoulou E, Bai MK, Elisaf M, Drosos AA. Extensive lymphadenopathy as the first clinical manifestation in systemic lupus erythematosus. Lupus 2000; 9: 140-3.
6. Afzal W, Arab T, Ullah T, Teller K, Doshi KJ. Generalized Lymphadenopathy as Presenting Feature of Systemic Lupus Erythematosus: Case Report and Review of the Literature. J Clin Med Res 2016; 8: 819-823.
7. Santana A, Lessa B, Galrão L, Lima I, Santiago M. Kikuchi- Fujimoto’s disease associated with systemic lupus erythematosus: case report and review of the literature. Clin Rheumatol 2005; 24: 60-3.